Published in J Invest Dermatol on February 01, 1978
Linear IgA dapsone responsive bullous dermatosis. J R Soc Med (1980) 0.94
Immunoelectron microscopic studies in IgA linear dermatosis. Arch Dermatol Res (1979) 0.75
Identification of papillomaviruses in butchers' warts. J Invest Dermatol (1981) 3.00
IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol (1984) 2.95
Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S A (1978) 2.26
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Preliminary, dermatologic first step criteria for lupus erythematosus and second step criteria for systemic lupus erythematosus. Int J Dermatol (1993) 2.05
Clinical significance of autoantibodies in pemphigus. Arch Dermatol (1966) 1.95
Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res (1972) 1.91
Studies in immunodermatology. VI. IF studies of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic lesions. Int Arch Allergy Appl Immunol (1975) 1.77
Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res (1979) 1.73
Carbohydrates of influenza virus. Structural elucidation of the individual glycans of the FPV hemagglutinin by two-dimensional 1H n.m.r. and methylation analysis. EMBO J (1985) 1.64
IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci (1983) 1.59
Studies in immunodermatology. VII. Four-compartment system studies of IgG in stratum corneum and of stratum corneum antigen in biopsies of psoriasis and control dermatoses. Int Arch Allergy Appl Immunol (1975) 1.52
Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol (1995) 1.45
Immunopathology of psoriasis. Arch Dermatol Res (1979) 1.26
"Bound" complement in the epidermis of patients with pemphigus vulgaris. Dermatologica (1967) 1.25
Immunofluorescence studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid. J Invest Dermatol (1971) 1.21
Pemphigus antibody action on skin explants: kinetics of acantholytic changes and stability of antigens in tissue cultures of normal monkey skin explants. Arch Dermatol (1977) 1.21
Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum (1997) 1.21
Factors contributing to occasional failures in demonstration of pemphigus antibodies by the immunofluorescence test. J Invest Dermatol (1969) 1.18
Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol (2002) 1.18
Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol (1975) 1.14
The presence of complement "bound" in vivo in the skin of patients with pemphigoid. Dermatologica (1968) 1.12
Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyllactosamine backbones with Gal beta(1-4)GlcNAc beta(1-6) repeating units. J Biol Chem (1989) 1.12
Autoimmunity in concurrent myasthenia gravis and pemphigus erythematosus. JAMA (1968) 1.10
Cell-mediated immunity (CMI) in psoriasis. Arch Immunol Ther Exp (Warsz) (1978) 1.10
Linear IgA bullous dermatosis. An immunologically defined disease. Int J Dermatol (1985) 1.08
Scl 70 antibody--a specific marker of systemic sclerosis. Br J Dermatol (1986) 1.05
Immunofluorescence tests. Clinical significance of sera and skin in bullous diseases. Int J Dermatol (1985) 1.04
Endomysial antibodies in the diagnosis of celiac disease and the effect of gluten on antibody titers. Immunol Invest (1989) 1.04
Disease specificity and dynamics of changes in IgA class anti-endomysial antibodies in celiac disease. J Pediatr Gastroenterol Nutr (1988) 1.04
Isolation and characterization of an I-active ceramide decasaccharide from rabbit erythrocyte membranes. Biochemistry (1981) 1.04
Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol (1990) 1.04
Earliest clinical and histological changes in psoriasis. Dermatologica (1981) 1.02
Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. Eur J Biochem (1990) 1.02
Solution conformations of GM3 gangliosides containing different sialic acid residues as revealed by NOE-based distance mapping, molecular mechanics, and molecular dynamics calculations. Biochemistry (1992) 1.00
[Bullous pemphiboid and Duhring's dermatitis herpetiformis: electron microscopy studies]. Arch Klin Exp Dermatol (1970) 0.99
Dermatitis herpetiformis and bullous pemphigoid. Intermediate and mixed forms. Arch Dermatol (1976) 0.99
IgA pemphigus foliaceus. Report of two cases and a review of the literature. J Am Acad Dermatol (1989) 0.99
IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol (1979) 0.99
Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol (1991) 0.99
Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions. Int J Cancer (1997) 0.98
High resolution nuclear magnetic resonance spectroscopy of glycosphingolipids. I: 360 MHz 1H and 90.5 MHz 13C NMR analysis of galactosylceramides. Chem Phys Lipids (1980) 0.98
Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol (1995) 0.98
IgA anti-endomysial antibody detection in the serum of patients with dermatitis herpetiformis following gluten challenge. Arch Dermatol Res (1985) 0.97
Mast cells in the initial stages of psoriasis. Arch Dermatol Res (1988) 0.96
Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma. Acta Derm Venereol (1979) 0.96
Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol (1997) 0.96
Immunology of celiac disease: tissue and species specificity of endomysial and reticulin antibodies. Int Arch Allergy Appl Immunol (1990) 0.96
Solution conformation of sialosylcerebroside (GM4) and its NeuAc(alpha 2----3)Gal beta sugar component. Eur J Biochem (1989) 0.95
Major oligosaccharides in the glycoprotein of Friend murine leukemia virus: structure elucidation by one- and two-dimensional proton nuclear magnetic resonance and methylation analysis. Biochemistry (1984) 0.95
Prevalence of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks (Acari, Ixodidae) in different Polish woodlands. Ann Agric Environ Med (1999) 0.95
Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity. Br J Dermatol (1984) 0.94
Autoimmunity in psoriasis. Relation of disease activity and forms of psoriasis to immunofluorescence findings. Arch Dermatol Res (1978) 0.94
Autoimmunity in psoriasis. A complement immunofluorescence study. Arch Dermatol Res (1978) 0.94
Organ culture studies of pemphigus antibodies. II. Ultrastructural comparison between acantholytic changes in vitro and human pemphigus lesions. J Invest Dermatol (1977) 0.93
Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol (1999) 0.93
Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood). Clin Dermatol (1992) 0.92
Role of cell-mediated immunity in spontaneous regression of plane warts. Int J Dermatol (1988) 0.92
Antigenicity of DNA induced by photoaddition of 8-methoxypsoralen. Photochem Photobiol (1978) 0.92
Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. J Eur Acad Dermatol Venereol (2005) 0.91
Immunologic phenomena in herpes gestationis. Arch Dermatol Forsch (1975) 0.91
Ultrastructural localization of pemphigus autoantibodies. J Invest Dermatol (1968) 0.91
Sensitivity and specificity of IgA-class antiendomysial antibodies for dermatitis herpetiformis and findings relevant to their pathogenic significance. J Am Acad Dermatol (1986) 0.91
Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. I. Selection of clinical groups and study factors. Int J Dermatol (1991) 0.91
Characterization of an autoantigen associated with chronic ulcerative stomatitis: the CUSP autoantigen is a member of the p53 family. J Invest Dermatol (1999) 0.91
Is papular acantholytic dyskeratosis of the vulva a new entity? Am J Dermatopathol (1984) 0.90
Structure elucidation by one- and two-dimensional 360- and 500-MHz 1H NMR of the oligosaccharide units of two glycoproteins isolated from alveoli of patients with alveolar proteinosis. Arch Biochem Biophys (1984) 0.90
Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3. J Am Acad Dermatol (2003) 0.90
Anticentromere antibody: an immunological marker of a subset of systemic sclerosis. Br J Dermatol (1985) 0.90
IgG endomysial antibodies in IgA-deficient patient with coeliac disease. Lancet (1989) 0.90
Congenital fascial dystrophy--a noninflammatory disease of fascia: the stiff skin syndrome. Pediatr Dermatol (1984) 0.89
Isolation and structural characterization of sialic-acid-containing glycopeptides of the O-glycosidic type from the urine of two patients with an hereditary deficiency in alpha-N-acetylgalactosaminidase activity. Biol Chem Hoppe Seyler (1989) 0.89
Unexpected similarity of the structures of the weakly toxic amanitin (S)-sulfoxide and the highly toxic (R)-sulfoxide and sulfone as revealed by proton nuclear magnetic resonance and X-ray analysis. Biochemistry (1983) 0.89
Deposition of fibrin-like material in early lesions of dermatitis herpetiformis. Ann Clin Res (1971) 0.89
MS and NMR analysis of the cross-reacting determinant glycan from Trypanosoma brucei brucei MITat 1.6 variant specific glycoprotein. Biochem Biophys Res Commun (1987) 0.89
On the viral etiology of epidermodysplasia verruciformis Lewandowsky-Lutz. Electron microscope studies. Dermatologica (1968) 0.88
Purification and structures of branched blood-group-B-active glycosphingolipids from human erythrocyte membranes. Eur J Biochem (1984) 0.88
Comparative studies of different gliadin preparations in detecting antigliadin antibodies. J Pediatr Gastroenterol Nutr (1986) 0.88
Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections. J Invest Dermatol (1987) 0.88
Structural analysis of glycosphinoglipids by high-resolution 1H nuclear magnetic resonance spectroscopy. Biochemistry (1980) 0.88
Cellular immunity in cutaneous and genital HPV infections. Clin Dermatol (1997) 0.88
IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and anti-gliadin antibodies. Br J Dermatol (1987) 0.87
T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5. Dermatologica (1981) 0.87
[Ultrastructure of melanosomes in malignant melanoma]. Dermatol Monatsschr (1970) 0.87
Structure determination of a ceramide pentadecasaccharide by two-dimensional J-resolved and J-correlated NMR spectroscopy. FEBS Lett (1982) 0.87
Continuous peritoneal dialysis for treatment of psoriasis. I. Depletion of PMNL as a possible factor for clearing of psoriatic lesions. Arch Dermatol Res (1979) 0.86
Morphea with high titer of fibronectin antibodies. Int J Dermatol (1992) 0.86
Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus? J Invest Dermatol (1979) 0.86
Immunological phenomena induced by UV rays. Acta Derm Venereol (1976) 0.86
Primary atrophic profound linear scleroderma. Report of three cases. Dermatology (2000) 0.86
Substrate specificity of antinuclear antibodies in scleroderma. J Invest Dermatol (1977) 0.85